Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, School of Chemistry, The University of Manchester, Princess Street, Manchester, M1 7DN, UK.
Analyst. 2018 Sep 24;143(19):4783-4788. doi: 10.1039/c8an00902c.
Chromatography-based mass spectrometry approaches (xC-MS) are commonly used in untargeted metabolomics, providing retention time, m/z values and metabolite-specific fragments, all of which are used to identify and validate an unknown analyte. Ion mobility-mass spectrometry (IM-MS) is emerging as an enhancement to classic xC-MS strategies, by offering additional ion separation as well as collision cross section (CCS) determination. In order to apply such an approach to a metabolomics workflow, verified data from metabolite standards is necessary. In this work we present experimental DTCCSN2 values for a range of metabolites in positive and negative ionisation modes using drift tube-ion mobility-mass spectrometry (DT-IM-MS) with nitrogen as the buffer gas. The value of DTCCSN2 measurements for application in metabolite identification relies on a robust technique that acquires measurements of high reproducibility. We report that the CCS values found for 86% of metabolites measured in replicate have a relative standard deviation lower than 0.2%. Examples of metabolites with near identical mass are demonstrated to be separated by ion mobility with over 4% difference in DTCCSN2 values. We conclude that the integration of ion mobility into current LC-MS workflows can aid in small molecule identification for both targeted and untargeted metabolite screening.
基于色谱的质谱方法(xC-MS)常用于非靶向代谢组学,提供保留时间、m/z 值和代谢物特异性片段,所有这些都用于鉴定和验证未知分析物。离子淌度 - 质谱(IM-MS)作为经典 xC-MS 策略的增强,通过提供额外的离子分离以及碰撞截面(CCS)的确定而崭露头角。为了将这种方法应用于代谢组学工作流程,需要具有经过验证的代谢物标准品数据。在这项工作中,我们使用氮气作为缓冲气体的漂移管 - 离子淌度 - 质谱(DT-IM-MS),在正离子和负离子模式下,对一系列代谢物的 DTCCSN2 值进行了实验测定。DTCCSN2 测量值在代谢物鉴定中的应用取决于一种获取高重现性测量值的稳健技术。我们报告说,在重复测量中,86%的代谢物的 CCS 值具有低于 0.2%的相对标准偏差。具有几乎相同质量的代谢物的例子被证明可以通过离子淌度分离,DTCCSN2 值相差超过 4%。我们得出结论,将离子淌度纳入当前的 LC-MS 工作流程可以有助于小分子的鉴定,无论是针对靶向还是非靶向的代谢物筛选。